| 证券代码 | MBII.O |
| 证券名称 | Marrone Bio Innovations Inc |
| 证券类型 | 美股 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | 主板 |
| 发行方式 | 公开发售 |
| 首发上市日 | 2013-08-02 |
| 首发价格(元) | 12 USD |
| 首发数量(股) | 4750000 |
| 首发募资额(元) | 57,000,000.00 USD |
| 首发主承销商 | Jefferies LLC,Piper Jaffray & Co |
| 货币单位 | USD |
| 公司名称 | Marrone Bio Innovations, Inc. |
| 注册地址 | 美国特拉华州 |
| 办公地址 | 1540 Drew Avenue, Davis, California, USA |
| 成立日期 | 2006-06 |
| 董事会主席 | Robert A. Woods |
| 公司属地 | United States 美国 |
| 公司网址 | www.marronebioinnovations.com |
| 电话 | +1 (530) 750-2800 |
| 传真 | - |
| 公司简介 | Marrone Bio Innovations, Inc. (NASDAQ: MBII) strives to lead the movement to more sustainable world through the discovery, development and sale of innovative biological products for crop protection, plant health and waterway systems treatment. MBI has screened over 18,000 microorganisms and 350 plant extracts, leveraging its in-depth knowledge of plant and soil microbiomes enhanced by advanced molecular technologies to rapidly develop seven effective and environmentally responsible pest management products to help customers operate more sustainably while uniquely improving plant health and increasing crop yields. |